AIN HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,953 JPY | +5.94% |
|
+1.76% | +33.06% |
| Sales 2024 | 400B 2.55B | Sales 2025 * | 414B 2.64B | Capitalization | 208B 1.33B |
|---|---|---|---|---|---|
| Net income 2024 | 11.4B 72.69M | Net income 2025 * | 10.08B 64.28M | EV / Sales 2024 | 0.52 x |
| Net cash position 2024 * | 46.9B 299M | Net cash position 2025 * | 55.1B 351M | EV / Sales 2025 * | 0.37 x |
| P/E ratio 2024 |
18.4
x | P/E ratio 2025 * |
20.7
x | Employees | 10,561 |
| Yield 2024 |
1.34% | Yield 2025 * |
1.11% | Free-Float | 76.47% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.94% | ||
| 1 week | +1.76% | ||
| Current month | +1.76% | ||
| 1 month | -1.81% | ||
| 3 months | +9.67% | ||
| 6 months | +26.12% | ||
| Current year | +33.06% |
1 week
5 521.00
6 020.00
1 month
5 521.006 087.00
Current year
4 353.006 268.00
1 year
4 023.006 268.00
3 years
4 023.008 350.00
5 years
4 023.008 350.00
10 years
2 250.009 330.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hideki Fujiwara
DFI | Director of Finance/CFO | - | - |
Kiichi Otani
PSD | President | 72 | 80-06-30 |
Takanobu Murase
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Junro Ito
BRD | Director/Board Member | 66 | 19-06-30 |
Kiichi Otani
PSD | President | 72 | 80-06-30 |
Shoichi Shudo
BRD | Director/Board Member | 64 | 82-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.66% | 13 M€ | +8.83% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 5,953 | +5.94% | 460,900 |
| 24-06-06 | 5,619 | -3.98% | 269,700 |
| 24-06-05 | 5,852 | -0.37% | 116,600 |
| 24-06-04 | 5,874 | +0.32% | 111,700 |
| 24-06-03 | 5,855 | +0.09% | 89,100 |
Delayed Quote Japan Exchange, June 07, 2024 at 02:00 am EDT
More quotes
AIN Holdings Inc is a Japan-based company engaged in the pharmacy business and retail business. The Company operates through three business segments. The Pharmacy segment consists of dispensing pharmacy, the sale of generic drugs, recruitment business focusing on doctors and pharmacists, and consulting services related to the management and opening of dispensing pharmacies. The Retail segment consists of the management of cosmetics and drug stores. The Others segment is engaged in the sale of cosmetics, food and beverages, and the rental of buildings.
Sector
Drug Retailers
Calendar
2024-08-29
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
5,953
JPY
Average target price
5,375
JPY
Spread / Average Target
-9.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +33.06% | 1.33B | |
| -12.43% | 346M | |
| -0.07% | 267M | |
| +10.56% | 227M | |
| -42.59% | 88.52M | |
| -14.68% | 81.59M | |
| +26.03% | 62.4M |
- Stock Market
- Equities
- 9627 Stock
